mRNex® T7 RNA Polymerase (low dsRNA, 250 U/μL)
An engineered T7 RNA polymerase designed to reduce double-stranded RNA by-products during in-vitro transcription.
T7-template compatibility
Buffer included
RUO
Product overview
mRNex® T7 RNA Polymerase (low dsRNA, 250 U/μL). An engineered T7 RNA polymerase designed to reduce double-stranded RNA by-products during in-vitro transcription.
Reduced dsRNA design
The mutant enzyme is described as producing less dsRNA than wild-type T7 polymerase.
T7-template compatibility
Accepts linearized plasmids and PCR products with a T7 promoter.
Buffer included
Supplied with 10× transcription buffer.
Specifications
| Parameter | Value |
|---|---|
| Activity concentration | 250 U/µL |
| Source | Recombinant E. coli |
| Applications | In-vitro RNA synthesis |
| Storage | −25 to −15°C, 1 year. |
| Intended use | Research use only |
Pack sizes & ordering
| Catalog No. | Pack size |
|---|---|
| LD203009 | 10 KU |
| LD203009 | 100 KU |
| LD203009 | 250 KU |
Source: LD203009_mRNex® T7 RNA Polymerase (low dsRNA, 250 U-μL)_10628ES.pdf, pp. 2–3.
Performance & validation
The handbook describes reduced dsRNA formation compared with wild-type T7 RNA polymerase. No numerical reduction percentage is used here. Source: LD203009 handbook/CoA, pp. 2–3.
Reduced dsRNA design
The mutant enzyme is described as producing less dsRNA than wild-type T7 polymerase.
T7-template compatibility
Accepts linearized plasmids and PCR products with a T7 promoter.
Buffer included
Supplied with 10× transcription buffer.
Product documents
Product FAQs
An engineered T7 RNA polymerase designed to reduce double-stranded RNA by-products during in-vitro transcription. −25 to −15°C, 1 year. No. It is for research use only.What is this product used for?
How should the product be stored?
Is this product intended for diagnostic or clinical use?